APA

Goldstein G., Conant M. A., Beall G., Grossman H. A., Galpin J. E., Blick G., Calabrese L. H., Hirsch R. L., Fisher A. & Stampone P. (19950321). Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. : Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Chicago

Goldstein G, Conant M A, Beall G, Grossman H A, Galpin J E, Blick G, Calabrese L H, Hirsch R L, Fisher A and Stampone P. 19950321. Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. : Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Harvard

Goldstein G., Conant M. A., Beall G., Grossman H. A., Galpin J. E., Blick G., Calabrese L. H., Hirsch R. L., Fisher A. and Stampone P. (19950321). Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. : Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

MLA

Goldstein G, Conant M A, Beall G, Grossman H A, Galpin J E, Blick G, Calabrese L H, Hirsch R L, Fisher A and Stampone P. Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial. : Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 19950321.